Open AccessImprovement in a Biomarker of Bone Formation during Infliximab Therapy in Pediatric Crohn's Disease: Results of the REACH Study
Author(s) -
Thayu M,
Leonard M,
Hyams J,
Crandall W,
Kugathasan S,
Otley A,
Olson A,
Liu G,
Marano C,
Heuschkel R,
VeeremanWauters G,
Griffiths A,
Baldassano R
Publication year - 2006
Publication title -
journal of pediatric gastroenterology and nutrition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.206
H-Index - 131
eISSN - 1536-4801
pISSN - 0277-2116
DOI - 10.1097/01.mpg.0000256207.34956.7d
Subject(s) - medicine , infliximab , biomarker , gastroenterology , n terminal telopeptide , bone remodeling , bone resorption , urine , pathogenesis , crohn's disease , bone disease , disease , endocrinology , osteoporosis , biochemistry , chemistry , alkaline phosphatase , osteocalcin , enzyme